DEEP VENOUS THROMBOSIS
Clinical trials for DEEP VENOUS THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new DEEP VENOUS THROMBOSIS trials appear
Sign up with your email to follow new studies for DEEP VENOUS THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood thinner tested for cancer Patients' clots – study halted early
Disease control TerminatedThis phase 3 trial tested a new drug, abelacimab, against a standard blood thinner (dalteparin) to prevent dangerous blood clots from returning in people with gastrointestinal or genitourinary cancers. The study enrolled 417 adults with advanced cancer and a recent clot. It was t…
Matched conditions: DEEP VENOUS THROMBOSIS
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Cancer clot study halted: new drug vs standard care
Disease control TerminatedThis study tested a new blood thinner, abelacimab, against the standard drug apixaban in about 1,150 people with cancer who had a blood clot. The goal was to see which drug better prevented new clots and caused less bleeding. The study was stopped early, but the results may still…
Matched conditions: DEEP VENOUS THROMBOSIS
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC